NasdaqGM - Nasdaq Real Time Price USD
Sutro Biopharma, Inc. (STRO)
0.8997
+0.0214
+(2.44%)
At close: May 20 at 4:00:00 PM EDT
0.8700
-0.03
(-3.30%)
After hours: May 20 at 6:30:14 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.53 | -0.45 | -2.16 | -0.68 |
| Low Estimate | -0.53 | -0.45 | -2.16 | -0.68 |
| High Estimate | -0.53 | -0.45 | -2.16 | -0.68 |
| Year Ago EPS | -0.56 | -0.5 | -2.56 | -2.16 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 10 |
| Avg. Estimate | 14.13M | 13.47M | 56.78M | 51.25M |
| Low Estimate | -- | -- | 17M | -- |
| High Estimate | 24.5M | 17.25M | 75.9M | 131.32M |
| Year Ago Sales | 25.71M | 8.52M | 62.04M | 56.78M |
| Sales Growth (year/est) | -45.02% | 58.14% | -8.49% | -9.73% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.9 | -0.74 | -0.95 | -0.63 |
| EPS Actual | -0.56 | -0.5 | -0.63 | -0.91 |
| Difference | 0.34 | 0.24 | 0.32 | -0.28 |
| Surprise % | 37.70% | 32.22% | 33.70% | -44.07% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.53 | -0.45 | -2.16 | -0.68 |
| 7 Days Ago | 0 | 0 | -2.48 | -0.67 |
| 30 Days Ago | 0 | -0.48 | -2.48 | -0.44 |
| 60 Days Ago | 0 | -0.48 | -2.48 | -0.44 |
| 90 Days Ago | -0.93 | -0.86 | -3.41 | -3.26 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STRO | 5.48% | 9.67% | 15.50% | 68.52% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Maintains | B of A Securities: Underperform to Underperform | 5/19/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 4/29/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 3/17/2025 |
| Downgrade | Citizens Capital Markets: Market Outperform to Market Perform | 3/14/2025 |
| Downgrade | Wedbush: Outperform to Neutral | 3/14/2025 |
| Downgrade | B of A Securities: Buy to Underperform | 3/14/2025 |
Related Tickers
MRSN Mersana Therapeutics, Inc.
0.3900
+1.30%
MGNX MacroGenics, Inc.
1.5700
-1.26%
ALEC Alector, Inc.
1.3700
+7.87%
CTMX CytomX Therapeutics, Inc.
2.0600
-3.29%
REPL Replimune Group, Inc.
9.19
+12.07%
AUTL Autolus Therapeutics plc
1.5300
+3.38%
FGEN FibroGen, Inc.
0.3442
+9.76%
ELEV Elevation Oncology, Inc.
0.3281
-3.50%
YMAB Y-mAbs Therapeutics, Inc.
4.2300
+1.44%
ANNX Annexon, Inc.
2.1000
+0.48%